Robert Goeltz II - 15 Dec 2024 Form 4 Insider Report for Arcus Biosciences, Inc. (RCUS)

Role
Chief Financial Officer
Signature
/s/ Carolyn Tang, Attorney-in-Fact
Issuer symbol
RCUS
Transactions as of
15 Dec 2024
Transactions value $
-$162,392
Form type
4
Filing time
17 Dec 2024, 20:36:19
Previous filing
25 Jan 2024
Next filing
03 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCUS Common Stock Tax liability -$162K -10.1K -13.68% $16.08 63.7K 15 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.